Related references
Note: Only part of the references are listed.Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma
Changming Shao et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy
Per Anderson et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Targeting KRAS in Colorectal Cancer
Chongkai Wang et al.
CURRENT ONCOLOGY REPORTS (2021)
RNA-Seq analysis of knocking out the neuroprotective proton-sensitive GPR68 on basal and acute ischemia-induced transcriptome changes and signaling in mouse brain
Guokun Zhou et al.
FASEB JOURNAL (2021)
Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer
Qiong-Yuan Chen et al.
FRONTIERS IN IMMUNOLOGY (2021)
Identification of a novel miR-21-3p/TGF-β signaling-driven immune escape via the MHC class I/biglycan axis in tumor cells
Karthikeyan Subbarayan et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Oncogenic KRAS creates an aspartate metabolism signature in colorectal cancer cells
Peter F. Doubleday et al.
FEBS JOURNAL (2021)
4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis
Yi Cheng Chu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Emerging strategies to target RAS signaling in human cancer therapy
Kun Chen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significance
Sandeep Appunni et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)
Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy
Li Cong et al.
BREAST CANCER RESEARCH (2021)
Mutant KRAS triggers functional reprogramming of tumor-associated macrophages in colorectal cancer
Huashan Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Role of cell surface proteoglycans in cancer immunotherapy
Nancy A. Espinoza-Sanchez et al.
SEMINARS IN CANCER BIOLOGY (2020)
Danger matrix molecules orchestrate CD14/CD44 signaling in cancer development
Heiko Roedig et al.
SEMINARS IN CANCER BIOLOGY (2020)
Microbiome analyses of blood and tissues suggest cancer diagnostic approach
Gregory D. Poore et al.
NATURE (2020)
Visualizing and interpreting cancer genomics data via the Xena platform
Mary J. Goldman et al.
NATURE BIOTECHNOLOGY (2020)
Revolutionizing the landscape of colorectal cancer treatment: The potential role of immune checkpoint inhibitors
Mai F. Tolba
INTERNATIONAL JOURNAL OF CANCER (2020)
RAS-targeted therapies: is the undruggable drugged?
Amanda R. Moore et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
RAS-targeted therapies: is the undruggable drugged? (vol 19, pg 533, 2020)
Amanda R. Moore et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
David S. Hong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Immune modulatory effects of oncogenic KRAS in cancer
Shaima'a Hamarsheh et al.
NATURE COMMUNICATIONS (2020)
Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients' Outcome
Karthikeyan Subbarayan et al.
CURRENT CANCER DRUG TARGETS (2019)
RAS-mediated oncogenic signaling pathways in human malignancies
Abdul Q. Khan et al.
SEMINARS IN CANCER BIOLOGY (2019)
Revisiting immune escape in colorectal cancer in the era of immunotherapy
Marieke Erica Ijsselsteijn et al.
BRITISH JOURNAL OF CANCER (2019)
Breaking down chronic inflammatory diseases: the role of biglycan in promoting a switch between inflammation and autophagy
Heiko Roedig et al.
FEBS JOURNAL (2019)
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
Suhas Vasaikar et al.
CELL (2019)
G12V and G12C mutations in the gene KRAS are associated with a poorer prognosis in primary colorectal cancer
Tamuro Hayama et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2019)
RAS mutations in human cancers: Roles in precision medicine
Avaniyapuram Kannan Murugan et al.
SEMINARS IN CANCER BIOLOGY (2019)
Molecular landmarks of tumor hypoxia across cancer types
Vinayak Bhandari et al.
NATURE GENETICS (2019)
Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers
Fengju Chen et al.
NATURE COMMUNICATIONS (2019)
Targeted Therapy in Metastatic Colorectal Cancer: Current Standards and Novel Agents in Review
Rebecca A. DeStefanis et al.
CURRENT COLORECTAL CANCER REPORTS (2019)
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Alison M. Taylor et al.
CANCER CELL (2018)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
Li Ding et al.
CELL (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
Katherine A. Hoadley et al.
CELL (2018)
Genetic Mechanisms of Immune Evasion in Colorectal Cancer
Catherine S. Grasso et al.
CANCER DISCOVERY (2018)
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
Qingsong Gao et al.
CELL REPORTS (2018)
Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells
Karthikeyan Subbarayan et al.
ONCOIMMUNOLOGY (2018)
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
Kyle Ellrott et al.
CELL SYSTEMS (2018)
RAS status and neoadjuvant chemotherapy impact CD8+cells and tumor HLA class I expression in liver metastatic colorectal cancer
Fanny Ledys et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology
Liliana Schaefer et al.
FEBS JOURNAL (2017)
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
Matthew A. Coelho et al.
IMMUNITY (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
Landscape of Microsatellite Instability Across 39 Cancer Types
Russell Bonneville et al.
JCO PRECISION ONCOLOGY (2017)
The extracellular matrix: Tools and insights for the omics era
Alexandra Naba et al.
MATRIX BIOLOGY (2016)
Decoding the Matrix: Instructive Roles of Proteoglycan Receptors
Thomas Neill et al.
BIOCHEMISTRY (2015)
Fermi orbital derivatives in self-interaction corrected density functional theory: Applications to closed shell atoms
Mark R. Pederson
JOURNAL OF CHEMICAL PHYSICS (2015)
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
Renato V. Iozzo et al.
MATRIX BIOLOGY (2015)
Expression and significance of biglycan in endometrial cancer
Yang Liu et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2014)
Proteogenomic characterization of human colon and rectal cancer
Bing Zhang et al.
NATURE (2014)
Drugging the undruggable RAS: Mission Possible?
Adrienne D. Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Biglycan enhances gastric cancer invasion by activating FAK signaling pathway
Lei Hu et al.
ONCOTARGET (2014)
Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis
Massimo Pancione et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
KRAS mutant allele-specific imbalance is associated with worse prognosis in pancreatic cancer and progression to undifferentiated carcinoma of the pancreas
Alyssa M. Krasinskas et al.
MODERN PATHOLOGY (2013)
HER-2/neu Mediates Oncogenic Transformation via Altered CREB Expression and Function
Andre Steven et al.
MOLECULAR CANCER RESEARCH (2013)
Inhibitory Role of the Small Leucine-Rich Proteoglycan Biglycan in Bladder Cancer
Christian Niedworok et al.
PLOS ONE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Connecting Genomic Alterations to Cancer Biology with Proteomics: The NCI Clinical Proteomic Tumor Analysis Consortium
Matthew J. Ellis et al.
CANCER DISCOVERY (2013)
Mutant allele-specific imbalance modulates prognostic impact of KRAS mutations in colorectal adenocarcinoma and is associated with worse overall survival
D. J. Hartman et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
HER-2/neu-mediated Down-regulation of Biglycan Associated with Altered Growth Properties
Christian V. Recktenwald et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Methylation of Cancer-Stem-Cell-Associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer Patients
Felipe de Sousa e Melo et al.
CELL STEM CELL (2011)
KRAS mutant allele-specific imbalance in lung adenocarcinoma
Simion I. Chiosea et al.
MODERN PATHOLOGY (2011)
Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine
G. Smith et al.
BRITISH JOURNAL OF CANCER (2010)
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting
Achilleas D. Theocharis et al.
FEBS JOURNAL (2010)
Expression of oncogenic K-ras and loss of Smad4 cooperate to induce the expression of EGFR and to promote invasion of immortalized human pancreas ductal cells
Shujie Zhao et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Identification of E2F1 as an Important Transcription Factor for the Regulation of Tapasin Expression
Juergen Bukur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Overexpressed vs mutated Kras in murine fibroblasts: a molecular phenotyping study
M. Horsch et al.
BRITISH JOURNAL OF CANCER (2009)
Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells
Christine Sers et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Altered Detoxification Status and Increased Resistance to Oxidative Stress by K-Ras Transformation
Christian V. Recktenwald et al.
CANCER RESEARCH (2008)
Aminopeptidase N (APN)/CD13-dependent CXCR4 downregulation is associated with diminished cell migration, proliferation and invasion
Jens Wulfaenger et al.
MOLECULAR MEMBRANE BIOLOGY (2008)
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Ali Mortazavi et al.
NATURE METHODS (2008)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer
Shang-rong Ye et al.
MODERN PATHOLOGY (2007)
Influence of Ki-ras-driven oncogenic transformation on the protein network of murine fibroblasts
Christian V. Recktenwald et al.
PROTEOMICS (2007)
Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features
IYS Tam et al.
CLINICAL CANCER RESEARCH (2006)
The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages
L Schaefer et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor β-induced cell motility
Y Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway
F Herrmann et al.
CANCER RESEARCH (2004)
Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-β in pancreatic tumor cells
WB Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
